x

Member Login

Publications

REMIT-UC

We are excited to share the first publication from the Canadian IBD Research Consortium: REMIT-UC was a multicenter cohort study looking at real-world effectiveness and safety of tofacitinib in ulcerative colitis. Many thanks to all the participating CIRC sites. This is just the first of many CIRC studies to come!

Access the publication here.